Aaron Royston
Partner · venBio Partners
Aaron Royston, a Managing Partner at venBio Partners, primarily invests in clinical-stage biotechnology and pharmaceutical companies developing novel therapeutics for unmet medical needs, with 75% of the firm's investments occurring at the Series A stage [1][2]. His check size typically ranges from 0 million to $30 million, with the firm deploying average investments of $30–$70 million per comp…
- Stages: Pre-Seed, Seed, Series A
- Focus: Healthcare
- Location: San Francisco, California, United States
LinkedIn
Browse all investors · Browse founders
